Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00125-012-2524-2.

Title:
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience | Diabetologia
Description:
Aims/hypothesis Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. Methods A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Results Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Conclusions/interpretation Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI. Trial registration: ClincalTrials.gov: NCT00000620 Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,182 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

creatinine, fenofibrate, participants, study, faci, renal, diabetes, baseline, increase, article, serum, google, scholar, accord, month, function, pubmed, clinical, cardiovascular, lipid, cas, level, trial, control, risk, patients, change, disease, usa, randomised, cvd, greater, table, characteristics, nhc, treatment, type, group, medication, analysis, research, levels, national, kidney, statin, placebo, status, tzd, blood, institute,

Topics {✒️}

peroxisome-proliferator-activated receptors alpha gov/scripts/cder/drugsatfda/index peroxisome proliferator-activated receptor chronic kidney disease-epidemiology peroxisome proliferator-activated receptors diabetes-induced experimental nephropathy pre-existing kidney disease albumin/creatinine ratio ≥ 35 mg/mmol open-label simvastatin therapy urinary albumin/creatinine ratio achieve ldl-cholesterol targets long-term renal function urinary/plasma inulin ratio long-term adverse effects end-stage renal disease long-term adverse effect urine albumin/creatinine ratio long-term fenofibrate therapy long-term fenofibrate treatment high-quality control samples abbott/merck schering plough/pfizer open-label simvastatin low-quality control samples long-term renal study cohort examined long-term efficacy privacy choices/manage cookies intra-assay cvs based raise hdl-cholesterol levels forward variable selection taking lipid-lowering medication statin ldl-cholesterol level full-dose medication 73 m2 received 54 mg/day albumin/creatinine ratio glomerular filtration rate sperl-hillen declare proteinuric renal disease kidney diseases urinary/plasma creatinine treatment strategy designed renal blood flow international diabetes center incident renal disease greater triacylglycerol-lowering response grey-filled boxes include genes related largest clinical trials mild renal insufficiency ldl-cholesterol level

Questions {❓}

  • Broeders N, Knoop C, Antoine M, Tielemans C, Abramowicz D (2000) Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
         description:Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI. Trial registration: ClincalTrials.gov: NCT00000620 Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
         datePublished:2012-03-27T00:00:00Z
         dateModified:2012-03-27T00:00:00Z
         pageStart:1641
         pageEnd:1650
         sameAs:https://doi.org/10.1007/s00125-012-2524-2
         keywords:
            Cardiovascular
            Creatinine
            Fenofibrate
            Outcomes
            Renal
            Internal Medicine
            Metabolic Diseases
            Human Physiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2524-2/MediaObjects/125_2012_2524_Fig1_HTML.gif
         isPartOf:
            name:Diabetologia
            issn:
               1432-0428
               0012-186X
            volumeNumber:55
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:D. E. Bonds
               affiliation:
                     name:National Institutes of Health
                     address:
                        name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:T. E. Craven
               affiliation:
                     name:Wake Forest School of Medicine
                     address:
                        name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Buse
               affiliation:
                     name:University of North Carolina School of Medicine
                     address:
                        name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. R. Crouse
               affiliation:
                     name:Wake Forest School of Medicine
                     address:
                        name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Cuddihy
               affiliation:
                     name:International Diabetes Center
                     address:
                        name:International Diabetes Center, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:US Medical Affairs of sanofi-aventis
                     address:
                        name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Elam
               affiliation:
                     name:Veteran’s Affairs Medical Center
                     address:
                        name:Veteran’s Affairs Medical Center, Memphis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. N. Ginsberg
               affiliation:
                     name:Columbia University College of Physicians and Surgeons
                     address:
                        name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. Kirchner
               affiliation:
                     name:Montgomery Veterans Administration Medical Center
                     address:
                        name:Montgomery Veterans Administration Medical Center, Jackson, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Marcovina
               affiliation:
                     name:University of Washington
                     address:
                        name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. C. Mychaleckyj
               affiliation:
                     name:University of Virginia
                     address:
                        name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. J. O’Connor
               affiliation:
                     name:HealthPartners Research Foundation
                     address:
                        name:HealthPartners Research Foundation, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J.-A. Sperl-Hillen
               affiliation:
                     name:HealthPartners Research Foundation
                     address:
                        name:HealthPartners Research Foundation, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
      description:Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI. Trial registration: ClincalTrials.gov: NCT00000620 Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
      datePublished:2012-03-27T00:00:00Z
      dateModified:2012-03-27T00:00:00Z
      pageStart:1641
      pageEnd:1650
      sameAs:https://doi.org/10.1007/s00125-012-2524-2
      keywords:
         Cardiovascular
         Creatinine
         Fenofibrate
         Outcomes
         Renal
         Internal Medicine
         Metabolic Diseases
         Human Physiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2524-2/MediaObjects/125_2012_2524_Fig1_HTML.gif
      isPartOf:
         name:Diabetologia
         issn:
            1432-0428
            0012-186X
         volumeNumber:55
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:D. E. Bonds
            affiliation:
                  name:National Institutes of Health
                  address:
                     name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:T. E. Craven
            affiliation:
                  name:Wake Forest School of Medicine
                  address:
                     name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Buse
            affiliation:
                  name:University of North Carolina School of Medicine
                  address:
                     name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. R. Crouse
            affiliation:
                  name:Wake Forest School of Medicine
                  address:
                     name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Cuddihy
            affiliation:
                  name:International Diabetes Center
                  address:
                     name:International Diabetes Center, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:US Medical Affairs of sanofi-aventis
                  address:
                     name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Elam
            affiliation:
                  name:Veteran’s Affairs Medical Center
                  address:
                     name:Veteran’s Affairs Medical Center, Memphis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. N. Ginsberg
            affiliation:
                  name:Columbia University College of Physicians and Surgeons
                  address:
                     name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. Kirchner
            affiliation:
                  name:Montgomery Veterans Administration Medical Center
                  address:
                     name:Montgomery Veterans Administration Medical Center, Jackson, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Marcovina
            affiliation:
                  name:University of Washington
                  address:
                     name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. C. Mychaleckyj
            affiliation:
                  name:University of Virginia
                  address:
                     name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. J. O’Connor
            affiliation:
                  name:HealthPartners Research Foundation
                  address:
                     name:HealthPartners Research Foundation, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J.-A. Sperl-Hillen
            affiliation:
                  name:HealthPartners Research Foundation
                  address:
                     name:HealthPartners Research Foundation, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Diabetologia
      issn:
         1432-0428
         0012-186X
      volumeNumber:55
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Institutes of Health
      address:
         name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:Wake Forest School of Medicine
      address:
         name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
         type:PostalAddress
      name:University of North Carolina School of Medicine
      address:
         name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
         type:PostalAddress
      name:Wake Forest School of Medicine
      address:
         name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
         type:PostalAddress
      name:International Diabetes Center
      address:
         name:International Diabetes Center, Minneapolis, USA
         type:PostalAddress
      name:US Medical Affairs of sanofi-aventis
      address:
         name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
         type:PostalAddress
      name:Veteran’s Affairs Medical Center
      address:
         name:Veteran’s Affairs Medical Center, Memphis, USA
         type:PostalAddress
      name:Columbia University College of Physicians and Surgeons
      address:
         name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
         type:PostalAddress
      name:Montgomery Veterans Administration Medical Center
      address:
         name:Montgomery Veterans Administration Medical Center, Jackson, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
         type:PostalAddress
      name:University of Virginia
      address:
         name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
         type:PostalAddress
      name:HealthPartners Research Foundation
      address:
         name:HealthPartners Research Foundation, Minneapolis, USA
         type:PostalAddress
      name:HealthPartners Research Foundation
      address:
         name:HealthPartners Research Foundation, Minneapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:D. E. Bonds
      affiliation:
            name:National Institutes of Health
            address:
               name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:T. E. Craven
      affiliation:
            name:Wake Forest School of Medicine
            address:
               name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
               type:PostalAddress
            type:Organization
      name:J. Buse
      affiliation:
            name:University of North Carolina School of Medicine
            address:
               name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:J. R. Crouse
      affiliation:
            name:Wake Forest School of Medicine
            address:
               name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
               type:PostalAddress
            type:Organization
      name:R. Cuddihy
      affiliation:
            name:International Diabetes Center
            address:
               name:International Diabetes Center, Minneapolis, USA
               type:PostalAddress
            type:Organization
            name:US Medical Affairs of sanofi-aventis
            address:
               name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
               type:PostalAddress
            type:Organization
      name:M. Elam
      affiliation:
            name:Veteran’s Affairs Medical Center
            address:
               name:Veteran’s Affairs Medical Center, Memphis, USA
               type:PostalAddress
            type:Organization
      name:H. N. Ginsberg
      affiliation:
            name:Columbia University College of Physicians and Surgeons
            address:
               name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
               type:PostalAddress
            type:Organization
      name:K. Kirchner
      affiliation:
            name:Montgomery Veterans Administration Medical Center
            address:
               name:Montgomery Veterans Administration Medical Center, Jackson, USA
               type:PostalAddress
            type:Organization
      name:S. Marcovina
      affiliation:
            name:University of Washington
            address:
               name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:J. C. Mychaleckyj
      affiliation:
            name:University of Virginia
            address:
               name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
               type:PostalAddress
            type:Organization
      name:P. J. O’Connor
      affiliation:
            name:HealthPartners Research Foundation
            address:
               name:HealthPartners Research Foundation, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:J.-A. Sperl-Hillen
      affiliation:
            name:HealthPartners Research Foundation
            address:
               name:HealthPartners Research Foundation, Minneapolis, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
      name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
      name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
      name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
      name:International Diabetes Center, Minneapolis, USA
      name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
      name:Veteran’s Affairs Medical Center, Memphis, USA
      name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
      name:Montgomery Veterans Administration Medical Center, Jackson, USA
      name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
      name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
      name:HealthPartners Research Foundation, Minneapolis, USA
      name:HealthPartners Research Foundation, Minneapolis, USA

External Links {🔗}(120)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.42s.